Foghorn Therapeutics Inc. (FHTX)
4.21
-0.03 (-0.71%)
At close: Jan 15, 2025, 12:02 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -2.75 | -2.44 | -8.24 | -10.69 | -12.91 | -13.51 |
| PS Ratio | 7.93 | 13.80 | 644.51 | 1.73K | n/a | n/a |
| PB Ratio | -3.51 | 2.37K | 8.78 | 5.10 | -7.58 | -9.06 |
| P/FCF Ratio | -2.27 | 1.38 | -15.87 | -15.71 | -14.1 | -14.7 |
| P/OCF Ratio | -2.29 | 1.37 | -16.92 | -23.84 | -14.4 | -15.7 |
| OCF/S Ratio | -3.46 | 10.07 | -38.1 | -72.76 | n/a | n/a |
| Debt / Equity Ratio | -0.58 | 459.88 | 0.60 | 0.56 | -0.19 | -0.18 |
| Quick Ratio | 4.11 | 1.03 | 9.44 | 10.12 | 1.33 | 11.68 |
| Current Ratio | 4.11 | 1.03 | 9.44 | 10.12 | 1.33 | 11.68 |
| Asset Turnover | 0.12 | 0.05 | 0.00 | 0.00 | n/a | n/a |
| Interest Coverage | n/a | n/a | -52.85 | -70 | -94.6 | -70.21 |
| Return on Equity (ROE) | 1.28 | -972.09 | -1.07 | -0.48 | 0.59 | 0.67 |
| Return on Assets (ROA) | -0.34 | -0.27 | -0.2 | -0.27 | -2.31 | -0.61 |
| Return on Capital (ROIC) | -0.47 | -1.72 | -0.21 | -0.29 | -5.27 | -0.66 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -221.15% | 99.90% | -469.75% | -13.32K% | n/a | n/a |
| Net Profit Margin | -288.17% | -566.23% | -7.83K% | -16.23K% | n/a | n/a |
| Pretax Profit Margin | -275.8% | -566.27% | -7.68K% | -16.00K% | n/a | n/a |
| Operating Profit Margin | -315.93% | -609.2% | -7.64K% | -15.94K% | n/a | n/a |
| FCF Margin | -349.38% | 1.00K% | -4.06K% | -11.04K% | n/a | n/a |
| EBITDA Margin | -305.83% | -591.93% | -7.29K% | -15.46K% | n/a | n/a |